New Key Statistics Module, Z-Score and F-Score
NAS:BNGO Key Ratios
| Market Cap $ M | 45.22 |
| Enterprise Value $ M | 53.85 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.46 |
| Price/Sales | 0.27 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 36.00 |
| EPS (TTM) $ | -7.18 |
| Beneish M-Score | -3.12 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 26.90 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.27 |
| EV-to-EBITDA | -0.29 |
| PEG | -- |
| Shares Outstanding M | 86.00 |
| Net Margin (%) | -557.98 |
| Operating Margin % | -282.07 |
| Pre-tax Margin (%) | -557.95 |
| Quick Ratio | 1.11 |
| Current Ratio | 1.63 |
| ROA % (ttm) | -106.85 |
| ROE % (ttm) | -172.09 |
| ROIC % (ttm) | -78.07 |
| Dividend Yield % | -- |
| Altman Z-Score | -10.83 |
BNGO Number of Guru Trades
BNGO Volume of Guru Trades
Gurus Latest Trades with NAS:BNGO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:BNGO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Bionano Genomics Inc Insider Transactions
No Available Data
News about NAS:BNGO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers